Bluestein Scott

CEO Bluestein Scott bought 7,000 shares of HTGC at $14.35 on 2026-02-27; stock now -33.6% from 52-week high amid cluster buy by 7 other insiders.

Chief Executive Officer Bluestein Scott purchased 7,000 shares for $100,450.00 on 2026-02-27, increasing his holdings to 2,516,379 shares, a 0.3% net increase in his position. This transaction occurs within a cluster of 7 other insider buys at the same company within the past 14 days, suggesting coordinated or simultaneous conviction at the current valuation. The stock currently trades at $14.21, representing a -33.6% decline from its 52-week high of $21.41 and a -23.3% decline over the past 30 days, indicating the purchase was made during a period of significant downward price pressure. The company shows a P/E of 6.73 with net income of $119,685,000.00 and a market cap of $2,610,312,159.77, providing fundamental context, though the timing relative to recent price deterioration and the multi-insider purchase cluster warrant attention to whether management views current levels as substantively undervalued.

CEO Scott Bluestein purchased 30,000 shares of HTGC at $15.08; 4 other insiders also bought within 14 days amid 31.5% decline from 52-week high.

Bluestein purchased 30,000 shares at $15.08, bringing his holdings to 2,509,379 shares and representing a +1.2% increase to his position. The purchase occurs while the stock trades at $15.07 current price, down -31.5% from its 52-week high of $22.00 and -19.1% over the past 30 days. Notably, a cluster pattern shows 4 other insiders also bought within the past 14 days, suggesting coordinated insider activity at depressed valuations. His prior transaction at HTGC was a sell on 2024-09-26, which achieved a 90-day return of +0.0%, and his cross-ticker track record shows 1 prior sale with a 90-day well-timed rate of 0.00%, indicating no consistent pattern of well-timed market exits. The company's fundamentals remain solid with net income of $119,685,000.00 and a P/E of 7.14, though the significant recent price decline warrants examination of what has driven the market repricing.

CEO Bluestein Scott sold 100,000 shares of HTGC at $19.59 on 2024-09-26 (current: $19.75).

Scott sold 100,000 shares valued at $1,958,640.00, reducing his holdings from 2,261,207 shares to 2,161,207 shares, a -4.4% reduction. At the transaction price of $19.59, Scott sold 8.1 basis points below the current price of $19.75, and the stock has risen 5.4% over the trailing 30 days. Scott retains 2,161,207 shares post-transaction, representing substantial continued ownership alignment with shareholders. The sale occurs with the stock trading -8.9% from its 52-week high of $21.67, within normal volatility ranges and without unusual context suggesting distress or urgent liquidation pressure.